|
Search
Collections
Benchmarks
Upload document
Product
UTAA06
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor
Clinical trial
Phase I Clinical Study of UTAA06 Injection in Treatment of Patients With Advanced Malignant Solid Tumors
Status: Recruiting
, Estimated PCD: 2024-12-01
